Skip to main content
Premium Trial:

Request an Annual Quote

Axxam Licenses Genedata's Screener Software

NEW YORK (GenomeWeb News) – Axxam has licensed Genedata’s data analysis and management software for use in its high-throughput screening programs, Genedata said today.
 
The multi-year agreement allows Axxam to implement the Genedata Screener software.
 
Axxam CEO Stefan Lohmer said the company’s focus extends beyond the actual license agreement to “a comprehensive, long-term partnership in high throughput screening.”
 
Genedata said the Screener’s architecture integrates with Axxam’s existing infrastructures and that it can be tailored for specific discovery processes.
 
Financial terms of the agreement were not released.
 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.